PRACA POGLĄDOWA
Perspektywy zastosowania leków ziołowych w związku z postępującym zanieczyszczeniem środowiska
 
Więcej
Ukryj
1
Department of Pathophysiology, Medical University, Lublin, Poland
2
Isobolographic Analysis Laboratory, Institute of Rural Health, Lublin, Poland
3
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Neurological Institute: Lou Ruvo Center for Brain Health, Departments of Psychiatry and Neurology as well as Huntington›s disease Center of Excellence, United States
4
Institute of Environmental Protection – National Research Institute in Warsaw, Poland
5
Department of Medical Anthropology, Institute of Rural Health, Lublin, Poland
AUTOR DO KORESPONDENCJI
Jarogniew J. Łuszczki   

Katedra i Zakład Patofizjologii Uniwersytetu Medycznego w Lublinie, Jaczewskiego 8b, 20-090, Lublin, Poland
 
Med Srod. 2019;22(1-2):5–8
 
SŁOWA KLUCZOWE
DZIEDZINY
STRESZCZENIE ARTYKUŁU
Wraz z rosnącym zanieczyszczeniem środowiska naturalnego zwiększa się również ilość zanieczyszczeń, które mogą gromadzić się w ziołach i roślinach wykorzystywanych do celów terapeutycznych w miarę ich wzrostu. Aby materiały roślinne miały właściwości lecznicze i mogły być stosowane jako środki lecznicze, należy je poddać rygorystycznej ocenie zgodnie z normami jakości materiałów. Obecnie nie ma jednak żadnej gwarancji, że nie nastąpiła zmiana ilości i zawartości leczniczych substancji bioaktywnych w roślinach wykorzystywanych do celów terapeutycznych w porównaniu z roślinami stosowanymi przed laty w tradycyjnej medycynie ludowej. Możliwości medycznego wykorzystania roślin są szerokie, zwłaszcza jeśli rośliny lecznicze są wolne od zanieczyszczeń pochodzących z zanieczyszczonego środowiska naturalnego. Uwaga badaczy powinna koncentrować się nie tylko na poszukiwaniu nowych bioaktywnych związków i odkrywaniu nowych substancji leczniczych w roślinach, ale także na zapewnieniu wysokich standardów czystości chemicznej roślin rosnących w środowisku narażonym na skażenie i zanieczyszczenie. Połączenie obu wyzwań może pomóc pacjentom cierpiącym na coraz większą liczbę dolegliwości i chorób cywilizacyjnych. Naukowcy muszą również aktywnie uczestniczyć w procesie wykrywania wszelkich szkodliwych substancji przenikających ze środowiska do roślin, stosując różne techniki biomedyczne i chemiczne, aby wykryć nieznane dotąd zagrożenia i tym samym uchronić przed nimi pacjentów.

Due to the increasing pollution of the natural environment, the amount of impurities that can accumulate in herbs and plants used for therapeutic purposes as medicinal plants also increases. As many plant materials have medicinal properties and have been used as medicinal remedies,they must be subjected to rigorous assessments according to material quality standards.Presently, however, there is no guarantee that there has been no change in the amount and content of medicinal bioactive substances, compared to plants used years ago in traditional folk medicine. At present, there are great prospects in the use of medical plants, especially if the medicinal plants are free from pollution originating from the contaminated natural environment. The attention of researchers should focus not only on seeking new bioactive compounds and finding new drugs in plants, but also on ensuring high standards of quality regarding the evaluation of the chemical purity of plants growing in the environment exposed to contamination and pollution. The combination of both challenges can help patients suffering from increasing numbers of ailments and diseases of civilization. Researchers must also be actively involved in the process of detection any harmful substances penetrating from the environment into plants by applying various biomedical and chemical techniques to detect some novel, as yet unknown threats, in order not to expose patients to them.
 
REFERENCJE (56)
1.
Leonti M, Verpoorte R. Traditional Mediterranean and European herbal medicines. J Ethnopharmacol. 2017; 199: 161–167.
 
2.
Zairi A, Nouir S, N MH, Bennani M, Bergaoui I, Mtiraoui A, et al. Antioxidant, antimicrobial and the phenolic content of infusion, decoction and methanolic extracts of thyme and rosmarinus species. Curr Pharm Biotech. 2018; 19(7): 590–599.
 
3.
Saeidnia S, Gohari AR, Manayi A. Reverse pharmacognosy and reverse pharmacology; two closely related approaches for drug discovery development. Curr Pharm Biotech. 2016; 17(11): 1016–1022.
 
4.
Zarshenas MM, Zargaran A. A review on the Avicenna›s contribution to the field of cardiology. Int J Cardiol. 2015; 182: 237–241.
 
5.
Shah SMA, Akram M, Riaz M, Munir N, Rasool G. Cardioprotective potential of plant-derived molecules: a scientific and medicinal approach. Dose Resp. 2019; 17(2): 1559325819852243.
 
6.
Nielsen E, Temporiti MEE, Cella R. Improvement of phytochemical production by plant cells and organ culture and by genetic engineering. Plant Cell Rep. 2019; 38(10): 1199–1215.
 
7.
Grof CPL. Cannabis, from plant to pill. Br J Clin Pharmacol. 2018; 84(11): 2463–2467.
 
8.
Heydari M, Hashempur MH, Zargaran A. Medicinal aspects of opium as described in Avicenna’s Canon of Medicine. Acta Med Hist Adriat. 2013; 11(1): 101–112.
 
9.
Trang T, Al-Hasani R, Salvemini D, Salter MW, Gutstein H, Cahill CM. Pain and poppies: the good, the bad, and the ugly of opioid analgesics. J Neurosci. 2015; 35(41): 13879–13888.
 
10.
Evans CJ. Secrets of the opium poppy revealed. Neuropharmacology. 2004; 47 Suppl 1: 293–299.
 
11.
Meijerink WJ, Molina PE, Abumrad NN. Mammalian opiate alkaloid synthesis: lessons derived from plant biochemistry. Shock. 1999; 12(3): 165–173.
 
12.
Brand EJ, Zhao Z. Cannabis in Chinese medicine: are some traditional indications referenced in ancient literature related to cannabinoids? Front Pharmacol. 2017; 8: 108.
 
13.
Kaur R, Ambwani SR, Singh S. Endocannabinoid system: a multi-facet therapeutic target. Curr Clin Pharmacol. 2016; 11(2): 110–117.
 
14.
Fraguas-Sanchez AI, Torres-Suarez AI. Medical use of cannabinoids. Drugs. 2018; 78(16): 1665–1703.
 
15.
Konduracka E. A link between environmental pollution and civilization disorders: a mini review. Rev Environ Health. 2019; 34(3): 227–233.
 
16.
Goralczyk K, Majcher A. Are the civilization diseases the result of organohalogen environmental pollution? Acta Bioch Pol. 2019; 66(2): 123–127.
 
17.
Steinhoff B. Review: Quality of herbal medicinal products: State of the art of purity assessment. Phytomedicine. 2019; 60: 153003.
 
18.
Kumar N, Kulsoom M, Shukla V, Kumar D, Priyanka, Kumar S, et al. Profiling of heavy metal and pesticide residues in medicinal plants. Environ Sci Pollut Res Int. 2018; 25(29): 29505–29510.
 
19.
Orru H, Ebi KL, Forsberg B. The interplay of climate change and air pollution on health. Curr Environ Health Rep. 2017; 4(4): 504–513.
 
20.
Stanojkovic-Sebic A, Maksimovic J, Dinic Z, Postic D, Ilicic R, Stanojkovic A. Microelements and heavy metals content in frequently utilized medicinal plants collected from the power plant area. Nat Prod Comm. 2017; 12(2): 185–188.
 
21.
Glavac NK, Djogo S, Razic S, Kreft S, Veber M. Accumulation of heavy metals from soil in medicinal plants. Arh Hig Rada Toksikol. 2017; 68(3): 236–244.
 
22.
Kohzadi S, Shahmoradi B, Ghaderi E, Loqmani H, Maleki A. Concentration, source, and potential human health risk of heavy metals in the commonly consumed medicinal plants. Biol Trace Elem Res. 2019; 187(1): 41–50.
 
23.
Ashiq S, Hussain M, Ahmad B. Natural occurrence of mycotoxins in medicinal plants: a review. Fungal Genet Biol. 2014; 66: 1–10.
 
24.
Kabak B, Dobson AD. Mycotoxins in spices and herbs-An update. Crit Rev Food Sci Nutr. 2017; 57(1): 18–34.
 
25.
Aghababaei R, Javadi I, Nili-Ahmadabadi A, Parsafar S, Ahmadimoghaddam D. Occurrence of bacterial and toxic metals contamination in illegal opioid-like drugs in Iran: a significant health challenge in drug abusers. Daru. 2018; 26(1): 77–83.
 
26.
Lawniczek-Walczyk A, Golofit-Szymczak M, Cyprowski M, Stobnicka A, Gorny RL. Monitoring of bacterial pathogens at workplaces in power plant using biochemical and molecular methods. Int Arch Occup Environ Health. 2017; 90(3): 285–295.
 
27.
Saikia J, Khare P, Saikia P, Saikia BK. Polycyclic aromatic hydrocarbons (PAHs) around tea processing industries using high-sulfur coals. Environ Geochem Health. 2017; 39(5): 1101–1116.
 
28.
Pandey A, Belwal T, Tamta S, Bhatt ID, Rawal RS. Phenolic compounds, antioxidant capacity and antimutagenic activity in different growth stages of in vitro raised plants of Origanum vulgare L. Mol Biol Rep. 2019; 46(2): 2231–2241.
 
29.
Roeder E, Wiedenfeld H, Edgar JA. Pyrrolizidine alkaloids in medicinal plants from North America. Pharmazie. 2015; 70(6): 357–367.
 
30.
Chen L, Mulder PPJ, Peijnenburg A, Rietjens I. Risk assessment of intake of pyrrolizidine alkaloids from herbal teas and medicines following realistic exposure scenarios. Food Chem Toxicol. 2019; 130: 142–153.
 
31.
Zaami S, Di Luca A, Di Luca NM, Montanari Vergallo G. Medical use of cannabis: Italian and European legislation. Eur Rev Med Pharmacol Sci. 2018; 22(4): 1161–1167.
 
32.
Parmar JR, Forrest BD, Freeman RA. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs. Res Social Adm Pharm. 2016; 12(4): 638–654.
 
33.
Thompson GR, Tuscano JM, Dennis M, Singapuri A, Libertini S, Gaudino R, et al. A microbiome assessment of medical marijuana. Clin Microbiol Infect. 2017; 23(4): 269–270.
 
34.
Booth JK, Page JE, Bohlmann J. Terpene synthases from Cannabis sativa. PloS One. 2017; 12(3): e0173911.
 
35.
Cromey MG, Drakulic J, Beal EJ, Waghorn IAG, Perry JN, Clover GRG. Susceptibility of garden trees and shrubs to Armillaria root rot. Plant Dis. 2019: Pdis06191147re.
 
36.
Gonzalez R, Butkovic A, Elena SF. Role of host genetic diversity for susceptibility-to-infection in the evolution of virulence of a plant virus. Vir Evol. 2019; 5(2): vez024.
 
37.
Redondo MA, Stenlid J, Oliva J. Genetic variation explains changes in susceptibility in a naive host against an invasive forest pathogen: the case of alder and the Phytophthora alni complex. Phytopathology. 2020. doi: 10.1094/PHYTO-07–19–0272-R.
 
38.
Alvarez A, Gamella JF, Parra I. Cannabis cultivation in Spain: A profile of plantations, growers and production systems. Int J Drug Pol. 2016; 37: 70–81.
 
39.
Gilbert AN, DiVerdi JA. Consumer perceptions of strain differences in Cannabis aroma. PloS One. 2018; 13(2): e0192247.
 
40.
Lenton S, Frank VA, Barratt MJ, Potter GR, Decorte T. Growing practices and the use of potentially harmful chemical additives among a sample of small-scale cannabis growers in three countries. Drug Alcohol Depend. 2018; 192: 250–256.
 
41.
Hu H, Wang L, Zhou Q, Huang X. Combined effects of simulated acid rain and lanthanum chloride on chloroplast structure and functional elements in rice. Environ Sci Poll Res Int. 2016; 23(9): 8902–8916.
 
42.
Takamatsu T, Watanabe M, Koshikawa MK, Murata T, Yamamura S, Hayashi S. Pollution of montane soil with Cu, Zn, As, Sb, Pb, and nitrate in Kanto, Japan. Sci Total Environ. 2010; 408(8): 1932–1942.
 
43.
Joshi SR. Airborne radioactive materials and plants: a review. Sci Total Environ. 1982; 24(2): 101–117.
 
44.
Zuin VG, Vilegas JH. Pesticide residues in medicinal plants and phytomedicines. Phytother Res. 2000; 14(2): 73–88.
 
45.
Szpyrka E, Slowik-Borowiec M. Consumer health risk to pesticide residues in Salvia officinalis L. and its infusions. J Environ Sci Health Part B. 2019; 54(1): 14–19.
 
46.
Ahmed MT, Loutfy N, Yousef Y. Contamination of medicinal herbs with organophosphorus insecticides. Bull Environ Contam Toxicol. 2001; 66(4): 421–426.
 
47.
Al-Waili N, Salom K, Al-Ghamdi A, Ansari MJ. Antibiotic, pesticide, and microbial contaminants of honey: human health hazards. Sci World J. 2012; 2012: 930849.
 
48.
Albert H, Busch J, Klier B, Klotzel M, Kuhn M, Steinhoff B. The occurrence of bromide in herbal drugs: is there a need for a Ph. Eur. limit? Pharmeur Bio Sci Notes. 2013; 2013: 40–63.
 
49.
Shrestha S, Kamel F, Umbach DM, Freeman LEB, Koutros S, Alavanja M, et al. High pesticide exposure events and olfactory impairment among U.S. farmers. Environ Health Perspect. 2019; 127(1): 17005.
 
50.
Palhares RM, Goncalves Drummond M, Dos Santos Alves Figueiredo Brasil B, Pereira Cosenza G, das Gracas Lins Brandao M, Oliveira G. Medicinal plants recommended by the world health organization: DNA barcode identification associated with chemical analyses guarantees their quality. PloS One. 2015; 10(5): e0127866.
 
51.
van Breemen RB, Fong HH, Farnsworth NR. Ensuring the safety of botanical dietary supplements. Am J Clin Nutr. 2008; 87(2): 509s-513s.
 
52.
Malone M, Tsai G. The evidence for herbal and botanical remedies, Part 1. J Family Prac. 2018; 67(1): 10–16.
 
53.
Malone M, Tsai G. The evidence for herbal and botanical remedies, Part 2. J Family Prac. 2018; 67(1): E1-E9.
 
54.
Coutinho Moraes DF, Still DW, Lum MR, Hirsch AM. DNA-based authentication of botanicals and plant-derived dietary supplements: where have we been and where are we going? Planta Med. 2015; 81(9): 687–695.
 
55.
WHO. Quality control methods for medicinal plant materials. Geneva, Switzerland: WHO Press; 2011. p. 1–173.
 
56.
Pielesz A. Vibrational spectroscopy and electrophoresis as a “golden means” in monitoring of polysaccharides in medical plant and gels. Spectrochim Acta A Mol Biomol Spectrosc. 2012; 93: 63–69.
 
eISSN:2084-6312
ISSN:1505-7054